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Background: A novel variant of the ST1-SCCmecIV methicillin-resistant Staphylococcus aureus (MRSA) lineage,
mostly associated with nosocomial bloodstream infections (BSI), has emerged in Rio de Janeiro. Bacterial biofilm has
been considered a major virulence factor in central venous catheter-associated BSI. The mechanisms involved in
biofilm formation/accumulation are multifactorial and complex. Studies have suggested that biofilm production was
affected in vitro and vivo for agr-null mutants of S. aureus.
Results: The impact of naturally occurring inhibition of agr signaling on virulence profiles and infections associated
with the ST1 variant was investigated. agr dysfunction was detected in a significant percentage (13%) of the isolates
with concomitant increase in biofilm accumulation in vitro and in vivo, and enhanced ability to adhere to and
invade airway cells. The biofilm formed by these ST1 isolates was ica-independent and proteinaceous in nature. In
fact, the improved colonization properties were paralleled by an increased expression of the biofilm-associated
genes fnbA, spa and sasG. The transcription of sarA, a positive regulator of agr, was two-times reduced for the
agr-dysfunctional MRSA. Remarkably, the agr inhibition was genetically stable. Indeed, agr-dysfunctional isolates
succeed to colonize and cause both acute and chronic infections in hospitalized patients, and also to effectively
accumulate biofilm in a mouse subcutaneous catheter implant model.
Conclusion: The ability of agr-dysfunctional isolates to cause infections in humans and to form biofilm in the
animal model suggests that therapeutic approaches based on agr-inactivation strategies are unlikely to be effective
in controlling human-device infections caused by ST1 isolates. The increased biofilm accumulation associated with
the acquisition of multiple antimicrobial resistant traits might have influenced (at least in part) the expansion of this
USA400 related clone in our hospitals.
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Community-acquired methicillin-resistant Staphylococcus
aureus (CA-MRSA) lineage ST1- SCCmec IV was first
reported in the 1980s among aborigines in Australia
(WA-1 clone) and in the USA (MW2/USA400 clone)
where cases of fatal infections were reported in Michigan,
Minnesota and North Dakota [1-3]. Nowadays, CA-MRSA
infections have been described in different countries
involving a number of genetically distinct lineages [4,5].
Many CA-MRSA isolates (including USA300, USA400
and USA1100) carry lukSF encoding for Panton-Valentine
leukocidin (PVL). Despite the controversy regarding the
role of the PVL, this leukocidin has been linked to severe
skin infections and necrotizing pneumonia [6-8]. In the
USA, USA300 has replaced USA400 as the predominant
clone in many communities [9]. However, USA400 isolates
were the main cause of an outbreak of skin infections that
occurred in rural southwestern Alaska, in 1996–2000 [10].
Indeed, USA400 was the far most common CA-MRSA
clone recovered from three northern remote communities
of Saskatchewan, Canada [11]. In 2005, a novel variant of
the lineage ST1-SCCmecIV emerged in Rio de Janeiro city
as an important cause of bloodstream infections (BSI) [12].
It is intriguing that despite the genetic relationship with
Australian WA-1 and MW2/USA400, isolates of this
novel clone were PVL-negative, multiresistant and mostly
involved in hospital-associated BSI [12]. It is still poorly
understood why isolates of CA-MRSA have become suc-
cessful so quickly [13]. Nevertheless, for hospital-associated
MRSA (HA-MRSA), the bacterial ability to produce biofilm
has been recognized as an important virulence factor for
the pathogenesis of intravenous catheter-related bacteremia
and infections associated with the use of medical prosthesis.
In addition, the bacterial ability to adhere to, colonize and
invade host tissues is considered important factor associ-
ated with bacterial virulence, adaptation and spread [14,15].
Different surface proteins have been implicated in biofilm
formation/accumulation and host colonization, including
fibronectin-binding proteins A and B (FnBPAB), S. aureus
surface protein G (SasG) and staphylococcal protein A (Spa)
[16-19]. In addition, extracellular DNA (eDNA) has also
been associated with bacterial biofilms [20].
It is also well known that virulence in S. aureus is
modulated by an intricate regulatory network [21]. The
accessory gene regulator (agr), the major S. aureus quorum
sensing system, down-regulates a number of genes
encoding for cell-surface proteins involved in colonization
processes, and up-regulates (by an indirect mechanism
involving RNAIII dependent down-regulation of Rot)
different exoproteins associated with host-cell damages
[22]. Previous works have suggested that inactivation of
Agr could be very effective at inhibiting S. aureus infections
[23], including those associated with implantable medical
devices [24,25]. Studies have demonstrated that biofilmproduction, host cell adhesion and invasion as well as
other mechanisms involved in the establishment and course
of staphylococcal diseases were affected by knockout of the
agr locus [26-28]. Despite the improvements achieved in
staphylococcal virulence, most of the investigations have
been carried out using relatively few laboratory construc-
tions or clinical isolates [28]. In addition, those results have
not been validated using current clinical isolates of MRSA.
In this paper we characterized the biofilm formed by
USA400-related (ST1-SCCmecIV) MRSA emergent in Rio
de Janeiro, investigated the adhesive and invasive properties
of naturally agr-dysfunctional isolates and analyzed
the impact of the agr inhibition on S. aureus infections
associated with the use of medical device. Our results
suggest that strategies based on agr inactivation approaches
may not be effective as an anti-biofilm strategy in the




All sixty ST1 isolates tested were able to produce biofilm on
inert surfaces. The majority (58.3% and 25%; respectively)
exhibited a moderate (BU varying from 0.468 to 0.901) or
strong (BU varying from 1.008 to 3.615) biofilm phenotypes
(Figure 1, top). For 19 randomly selected isolates, the
ability to accumulate biofilm on human Fn-coated surfaces
increased significantly (p<0.01 to p<0.0001) when com-
pared with that on inert surfaces (Figure 1, bottom).
Proteinaceous nature of the biofilm
Treatment with proteinase K virtually disrupted preformed
biofilms for 12 ST1 isolates tested. However, the carbohy-
drate oxidant metaperiodate almost did not affect the bio-
film accumulated by these isolates (Figure 2, top). CLSM
studies revealed that the agr-dysfunctional 08–008 accumu-
lated a denser and compact biofilm when compared to the
heterogeneous film formed by the agr-functional isolate
(96/05). Despite the stronger biofilm phenotype displayed
by the isolate 08–008, proteinase K could significantly
remove the biological film accumulated (Figure 2, bottom).
Role of eDNA in ST1 biofilm
No correlation was detected between the activity of
bacterial DNase and the levels of biofilm accumulated
by 17 USA400-related isolates displaying strong, moderate
or weak biofilm phenotypes (Figure 3, top). The addition of
28U/well DNase I in the culture media did not significantly
affect the biofilm formed by these ST1 isolates. However,
when this concentration was increased to 56U/well,
a significant (p=0.0078) reduction of 31% in biofilm
accumulation was detected (BU untreated =0.91±0.1 and
treated =0.63±0.078; Figure 3, left bottom). In addition, the
concentration of eDNA recovered from the supernatant of
Figure 1 Biofilm formed by ST1 isolates. Top: Percentage of the total 60 ST1 isolates displaying strong, moderate and weak biofilm
phenotypes. Wells show the different biofilm phenotypes formed on inert polystyrene surfaces by representative ST1 isolates. Bottom: Biofilm
formed on inert or fibronectin-coated surfaces by 19 ST1 isolates.
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08–008 was 182 ng/mL, three-times higher than that
determined for the weaker producer (BU=0.348±0.01)
isolate 117/05 (Figure 3, right bottom). In agreement
with these results, we have also detected a moderate
correlation (r=0.59) between bacterial autolysis and
biofilm accumulation, when 4 stronger biofilm producers
were compared with the same number of weaker producers
(Figure 4).
agrRNAIII inhibition
About 13% (8/60) of the USA400 related isolates exhibited
no apparent hemolytic activity (Figure 5, top right). These 8
isolates had almost undetectable agr expression by
RT-qPCR (Figure 5, top left). Of significance is the fact
that 4 out of 8 agr-dysfunctional MRSA were recovered
from BSI (50%). The RNAIII transcriptional levels for the 8
agr-functional isolates analyzed were significantly lower
than that of strain RN6390B (Figure 5, top left). When we
correlated the biofilm values (BU) with the levels of RNAIII
transcription, we found that the population of clinical
isolates with no hemolytic activity showed significant
increase (p=0.01) in biofilm formation/accumulation
(Figure 5, bottom). No significant difference could be
detected in the values of oxacillin MIC when agr-functional
(MIC90 = 128μg/mL) were compared with agr-dysfunctional
isolates (MIC90 = 128μg/mL). Indeed, when we quantified
mecA transcripts for 5 ST1 isolates, 08–008 (RQ=0.06±0.004), 89/05 (RQ=1.194±0.1), 08–068 (RQ=2.841±0.816),
07–135 (RQ=1.867±0.69), 07–058 (RQ=1±0.62), displaying
different levels of agr expression (Figure 5, top left), we
could not find a negative linear correlation between mecA
and agr expressions (correlation coefficient, r = 0.823).
Thus, an overexpression of mecA can not to be implicated
in the inhibition of RNAIII transcription. Because agr is
positively regulated by SarA, the expression of sarA gene
was also analyzed by RT-qPCR. Our data showed a
significant (p=0.0052) attenuation of sarA for the agr-
dysfunctional isolate 08–008 when compared with the
agr-functional 96/05 (Figure 6).
Animal model
The naturally agr-dysfunctional MRSA was able to colonize
and grow on the surface of implanted catheter fragment,
as well as to accumulate an increased amount of biofilm
(2-log CFU/mL) when compared with the agr-functional
isolate (Figure 7, top). The stability of the agr expression
in the agr-dysfunctional MRSA was examined by observing
the hemolytic activity of individual colonies. No hemolytic
halo was detected before and after passages in mice
(Figure 7, bottom).
Expression of agr-regulated genes
Total RNA obtained from isolates with significant differ-
ences (p<0.001) in the RNAIII transcription level (08–008;
RQ=0.0001±0.16 and 96/05; RQ=0.53±0.13) was used to
Figure 2 Proteinaceous nature of the biofilm. Top: Effect of 1mM/well sodium metaperiodate or 6U/well proteinase K on preformed biofilm.
Wells show the effect of these compounds on biofilms preformed on inert polystyrene surfaces by representative ST1 isolates. Bottom: Confocal
laser scanning microscopy (CLSM) images of proteinase K-treated and -untreated biofilms stained with SYTO 9. The square indicates the slice of
the biofilm from which the XY image was taken. The horizontal bar indicates the location of the X plane from which the cross-section was taken.
Isolate 08–008 (strong biofilm producer, agr-dysfunctional), 96/05 (moderate biofilm producer, agr-functional).
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regulated by agr. As expected, the agr-up-regulated hla was
less expressed (p<0.01) in the isolate 08–008 (Figure 8)
when compared with the isolate 96/05 (RQ=0.05±0.01 and
RQ=0.33±0.05, respectively). Similar pattern of expression
was found for another agr-up-regulated gene, psmα
(RQ96/05=75.90±0.10 and RQ08-008=0.005±0.12; p<0.001),
except that in this case we also observed a very high
expression of psmα for 96/05 (Figure 8). To verify if
this amplified expression was a characteristic of this
MRSA clone, other agr-functional isolates were randomly
selected for testing. High level of psmα transcripts
was also detected for the isolates 07–035, 07–059 and
08–068 (RQ07 035=35.71±0.06; RQ07-059=48.90±0.07;
RQ08-068=31.30±0.07). For all virulence genes tested,
the expression of the agr-functional isolate BMB9393
was higher than that of USA400-related isolates, except
for psmα gene (Figure 8). Accordingly, the RNAIII-
down-regulated spa gene showed a very significant
lower expression (p<0.001) in the agr-functional 96/05
(RQ=0.8±0.20) compared with the agr-dysfunctional
isolate 08–008 (RQ= 52.8±0.17; Figure 8).Expression of biofilm-associated genes fnbAB, sasG and spa
The agr-dysfunctional isolate 08–008, which showed
increased biofilm accumulation in vitro and in vivo,
had a significant increase (p=0.02) in fnbA transcripts
(RQfnbA=10.08±0.18) when compared with the isolate
96/05 RQfnbA=4.91±0.19; Figure 8). However, no significant
difference was detected when fnbB expression were ana-
lyzed (RQ96/05 =0.11±0.04; RQ08-008 =0.18±0.05; Figure 8).
Similarly to fnbA, the expression of sasG (Figure 8; p=0.03)
and spa (Figure 8; p<0.001) was also increased in 08–008
(RQsasG=1.13±0.11; RQspa=52.8±0.17) compared with
96/05 isolate (RQsasG=0.65±0.14; RQspa=0.8±0.20).
Adherence and invasion
The naturally agr-dysfunctional isolate 08–008 showed
significant increase (p<0.05) in the adherence to human
airway cells, reaching 25.27%±0.4% at 3h30min of incuba-
tion. In contrast, at the same conditions, the adherence of
the agr-functional (isolate 96/05) to airway cells occurred
in much less extent (4.94%±0.2%). Similarly, invasion was
also higher for the agr-dysfunctional isolate (6.37%±0.3%)
when compared with the agr-functional (1.76%±0.2%) at
Figure 3 Bacterial DNase activity, treatment of the biofilm with DNase I and eDNA assay. Top: DNase activity was detected in culture
supernatants of 16 ST1 isolates by measuring the halo size (cm) produced on Difco™ DNase Test Agar (BD). BU: Biofilm values for 16 ST1 isolates
using inert polystyrene. Left bottom: For 16 ST1 isolates, 56U/well of DNase I were added to the culture media and the amount of biofilm
accumulated determined. Right bottom: The concentration of eDNA determined in the biofilm supernatant. Isolate 08–008 (strong biofilm
producer, agr-dysfunctional), 96/05 (moderate biofilm producer, agr-functional).
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invasive ability in the stationary phase was observed
for the agr-knockout MHC474 (10.6%±0.3%) when
compared with the wild type (HC474; 2.8%±0.1%) and
complemented construction CMHC474 (2.3%±0.1%;
p=0.0033; Figure 9, bottom).Figure 4 Autolysis assays for USA400-related isolates. 07–058,
105/05, 107/05 are strong biofilm producers; 07–035, 07–042, 07–135
moderate; and 07–062, 117/05 weak producers.Discussion
The great majority of the USA400-related isolates
(50/60; 83.3%) were able to accumulate strong/moderate
biofilms on polystyrene surfaces. The isolates remaining
produced weak biofilms. The ability to accumulate biofilm
increased when the surfaces were covered with human
fibronectin, as also reported by others [19,29]. In opposition
to our results, it was reported that MW2 MRSA had a
weak biofilm phenotype [30,31]. Similarly, a slight biofilm
accumulation (OD=0.25-0.3) was observed for another
USA400 strain called BAA-1683 [32]. In addition, recent
data from our laboratory (Ramundo MS & Figueiredo
AMS, 2012; unpublished observations) showed that
another SCCmecIV isolates (ST30 CA-MRSA) accumulated
much lower amount of biofilm compared with ST1-SCC
mecIV isolates.
Previous data from our group [12] have also demonstrated
that the ST1 isolates from Rio de Janeiro do not carry lukSF
genes and have acquired a number of antimicrobial
resistance traits. Thus, it is possible that the enhanced
ability to accumulate biofilm, associated with the biological
cost of acquired resistance and the absence of PVL,
might have been the results (at least in part) of the
Figure 5 agr differential expression in USA400-related isolates. Top left: rnaIII expression was analyzed by RT-qPCR using ΔΔCT comparative
method. RQ: Relative quantity, (BSI): bloodstream infection, (CT): catheter tip, (P): Pneumonia, (C): colonization and (PF): prosthesis fragment. Top
right: The arrow indicates the arrow-tip-like zone of the δ-hemolysin activity on sheep blood agar. Bottom: Mean biofilm values (BU) for the
populations formed by isolates showing hemolytic activity or absence of hemolysis.
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in a previously community pathogen, promoting enhanced
bacterial fitness to spread in hospitals and cause health-care
associated diseases. The ica-independent nature of the
biofilm formed by USA 400-related isolates was revealed
by the disruption of bacterial film by proteinase K. SimilarFigure 6 Transcriptional levels of sarA determined by using
ΔΔCT comparative method. (1) USA400-related isolates 08–008
(agr-dysfunctional) and (2) 96/05 (agr-functional). (3) BMB9393 was used
as a control and (4) RN6390B as calibrator. RQ: Relative quantity.results were also observed by others using different MRSA
isolates [33,34]. Some researchers have suggested that the
bacterial autolysis increases eDNA concentration and,
consequently, enhances the level of biofilm accumulation
[20]. In fact, in our study, we observed a moderate
correlation between biofilm accumulation and autolysis. In
addition, we detected threefold increase in eDNA for the
ST1 MRSA displaying enhanced ability to accumulate
biofilm. Indeed, the addition of DNase I (56U/Well) caused
a significant reduction (about 30%) in biofilm accumulation,
suggesting eDNA cooperatively contributes to the biofilm
architecture of ST1 isolates.
The statistical analysis showed that the group of clinical
isolates with no hemolytic activity (agr-dysfunctional) had
significant increase in the level of biofilm accumulation
when compared with agr-functional isolates. These data are
in agreement with previous studies for agr-laboratory
knockouts [27,35,36], which have indicated that some
agr mutants can display increased levels of biofilm
accumulation. In spite of that, using another S. aureus
strain it was reported that inhibition of agr reduced biofilm
accumulation significantly [24,25]. In fact, agrRNAIII is a
negative regulator of different surface proteins [22,23], and
consistent with this regulation, amplified expression of
genes encoding for biofilm-associated proteins FnBPA,
Figure 7 In vivo biofilm accumulation and stability of agr
inhibition. Top: For the foreign body animal model, data were
transformed in percentage considering the CFU/mL of the isolate
08–008 as the reference value (100%). Bottom: The stability of agr
inhibition was tested by examining the hemolytic activity of
individual colonies of the isolates 08–008 before (left) and after
(right) passage in the animal.
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Both FnBPA and B have been implicated as major proteins
for biofilm formation/accumulation in S. aureus [19,33].
However, despite the detection of an enhanced expression
of fnbA, we could not find a significant increase in the
transcription of fnbB-mRNA for the agr-dysfunctional
ST1-MRSA. Equally, a study from Wolz and collabora-
tors suggested that fnbB was not significantly affected
by agr [36].
Confirming the agr inhibition detected, the expression
of two genes up-regulated by RNAIII, hla and psmα, was
lower compared with the agr-functional MRSA. Both
cytolysins (HLA and PSMα) seem to have remarkable
roles in the pathogenesis of S. aureus. HLA has been
associated with lethal pneumonia in USA400 and USA300
strains [37,38]. It was also previously found that psmα-
deleted mutant of CA-MRSA exhibited attenuated viru-
lence in animal models [39]. In this study, we detected
a superior expression of pmsα by the agr-functional isolates
of USA400-related clone detected in Rio de Janeiro. In
fact, it was shown by others that the transcription of
psmα-mRNA was increased in most prevalent CA-MRSA
lineages, including MW2, compared with other S. aureus
isolates [39]. However, the molecular mechanisms involvedwith the enhanced expression of PSMα were not clarified
[39]. Despite the importance of these virulence factors for
S. aureus pathogenicity, it is remarkable that among the
agr-dysfunctional variants, 4 were recovered from cases of
BSI, 2 from colonization, 1 from pneumonia and 1 from
infected prosthesis, showing that these variants were able to
colonize and cause both severe acute (pneumonia and BSI)
and chronic (foreign-body infection) staphylococcal diseases
in humans. These data demonstrated that regardless the
reduced virulence of agr-laboratory knockouts in some
animal models [40], the virulence of naturally dysfunctional
agr variants was confirmed for hospitalized patients. In
contrast to the assumption that agr-dysfunctional isolates
may not be able to initiate infections [41], the isolate
08–008 was able to colonize polyurethane endovenous
catheter in a foreign-body mouse model, forming a
denser biofilm accumulation when compared with the
agr-functional isolate. It is important to state that because
the ST1 isolates studied were not isogenic, it is possible
that factors other than the inhibition of agr might also
have accounted for the increased biofilm accumulation
observed. Nevertheless, supporting our data, similar
increase of the biofilm formed on catheters implanted
in mice was previously reported for an agr laboratory
knockout [28]. In opposition to the results obtained by
Traber et al. [41], all individual colonies formed by the
agr-dysfunctional MRSA remained non-hemolytic before
and after passages in mice, strongly suggesting the genetic
stability of the phenotype. This stability was confirmed
for all agr-dysfunctional isolates from our collection.
Corroborating our findings, while we were finishing
this manuscript, we noticed the work by Park et al. [42]
that found agr dysfunction in S. aureus significantly
associated with persistent bacteremia with eradicated
foci, even though the predominant MRSA isolates
showed SCCmecII, agrII (possible belonging to USA100-
New York/Japan clone) while the isolates studied here
displayed SCCmecIV, agrIII and clustered in USA400-
MW2/WA-1 clone. In fact, the bacterial ability to adhere
to and invade epithelial cells, and consequently evade host
defense mechanisms, has already been associated with
persistence in host cells and development of disseminated
infections [43,44]. In the present study, the differential
expression of agrRNAIII in MRSA clinical isolates had
a significant impact on adherence and invasion at
3h30min incubation. The same impact was observed
for the agr isogenic knockout, as previously showed by
others using different cell lines and mostly laboratory
mutants [26,45].
Recently, Pozzi et al. demonstrated that high level of
PBP2a expression by the homogeneous methicillin-resistant
derivative of the strain 8325–4 induced a proteinaceous
biofilm and significant repression of the agr locus [46]. In
addition, excision of the SCCmec element from the MRSA
Figure 8 Transcriptional levels of virulence-associated genes determined by RT-qPCR, using ΔΔCT comparative method. (1) USA400-related
isolates 08–008 (agr-dysfunctional) and (2) 96/05 (agr-functional). (3) BMB9393 was used as a control and (4) RN6390B as calibrator. RQ: Relative quantity.
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had the opposite effect on biofilm and lead to an increase
of the agrRNAIII transcription. In addition, Rudkin et al.
showed that methicillin resistance reduced the virulence
of HA-MRSA by interfering with agr [47]. The great
majority of ST1 isolates studied had MIC of 128 μg/mL
(agr-functional or -dysfunctional), which is compatible
with heterogeneous resistance to this drug. Indeed, mecA
overexpression was not detected in the agr-dysfunctional
isolates tested. SarA, a global transcriptional regulator of
S. aureus, was previously found to be a positive regulator
of agr and of biofilm formation/accumulation [21,48].
Thus, aiming to understand the mechanism involved in
agr impairment in these clinical isolates, the level of sarA
transcripts was also examined. It was observed that
sarA expression was significantly diminished in the
agr-dysfunctional compared with the agr-functional
MRSA, suggesting the defect was upstream agr. Beeken
et al. indicated that sarA repression inhibited biofilm
accumulation due to SarA inhibition of both proteases
and nucleases activity either in the presence or absence
of agr mutations [49]. In contrast, the results obtained
here demonstrated that agr-dysfunctional isolates showed
increased biofilm accumulation, despite the fact that
sarA-mRNA transcripts were reduced. In fact, other
studies have showed that sarA or agr-sarA laboratorymutants had lower ability to bind to fibronectin due to
sarA down-regulation of fnbA transcription [36]. Possible
explanations for this apparent divergence could be the fact
that the agr-dysfunctional ST1 studied showed only partial
sarA inhibition, or may display strain-dependent variation
in the genetic background affecting other genes apart to
those studied.
Conclusion
Isolates of this novel hospital-associated USA400 clone
were able to accumulate moderate/strong amount of
biofilms, in vitro and in vivo, and could efficiently adhere
to and invade human airway cells. Moreover, agr inhibition
was an ordinary phenomenon among those isolates, which
seems to have impacted the expression of some important
virulence genes studied. Although it is difficult to interpret
in vitro studies in the light of what occurs in an infected
human host, it follows logical that the enhanced adhesive
properties combined with the acquisition of multiple drug
resistance traits by ST1 isolates could have provided fitness
advantages for spreading in hospital environments. Indeed,
agr-dysfunctional isolates were recovered from cases of
hospital pneumonia, bacteremia and infected prosthesis.
Finally, our results strongly suggest that strategies for con-
trolling MRSA biofilm based on agr inhibition approaches
are unlikely to be effective, at least for ST1 MRSA isolates.
Figure 9 Adherence and invasion assays using human bronchial
epithelial cell line (16HBe14o-). Top: 96/05 (agr-functional) and
08–008 (agr-dysfunctional). Bottom: Invasion assay was also determined
after 3h30 min for the wild-type strain HC474, isogenic agr knockout
MHC474 (Δagr::tetM) and the rnaIII-trans-complemented construction
CMHC474 (Δagr::tetM, pbla-rnaIII).
Ferreira et al. BMC Microbiology 2013, 13:93 Page 9 of 12
http://www.biomedcentral.com/1471-2180/13/93Methods
Isolates
Sixty USA400-related isolates were obtained from patients
located in different hospital wards in Rio de Janeiro as part
of standard clinical care. Thirty isolates were recovered
from BSI (50%) and 8 from catheter tips (CT; 13.3%). The
remaining were from colonization (C; 13.3%), pneumonia
(P; 6.7%), skin/soft tissue infections (SSTI; 5%), urinary
tract infections (UTI; 3.3%) and prosthesis fragment
(PF; 1.7%). The infection sites had not been reported
for 4 isolates. The agr-knockout MNY474 (Δagr::tetM)
and the rnaIII-trans-complemented mutant CMNY474
(Δagr::tetM, pbla-rnaIII) were previously constructed
from the clinical S. aureus isolate NY474 [27]. BMB9393
(ST239-SCCmecIII) was used as positive control for
biofilm and gene expression experiments [27]. TheS. aureus RN4220 and RN6390B, a gift from Richard
Novick (New York University), were used for hemolytic
activity and gene expression analyses; respectively. This
study was approved (#1055/09) by the Human Research
Ethics Committee from Federal University of Rio de Janeiro,
RJ, Brazil.
Minimal inhibitory concentration (MIC)
Oxacillin MIC was determined using Müller Hinton plates
and performed in accordance with the Clinical Laboratories
Standards Institutes (CLSI) guidelines [50].
In vitro biofilm assay
For all 60 isolates, biofilm was tested using 96-well inert
polystyrene microtiter plates (Nunclon; Nunc A/S, Roskilde,
Denmark) as previously described [28]. The biofilm unit
(BU) was defined as indicated by Amaral et al. [14] and the
isolates were classified as non-producers (BU≤0.230), weak
(BU>0.230 and ≤0.460), moderate (BU>0.460 and ≤0.920)
or strong producers (BU>0.920), as suggested [14]. For
19 isolates, biofilm assays were also carried out on surfaces
covered with human fibronectin (Merck; Darmstadt,
Germany) as previously described [28].
In some experiments, before treatment with crystal
violet, the biofilm was treated with sodium metaperiodate
(10mM/well; Sigma; St. Louis, MO, USA) or proteinase
K (6U/well, Invitrogen; Carlsbad, California, EUA) [27].
Confocal laser scanning microscopy (CLSM) was employed
to record and contrast structural images of the biofilm
as described [28]. eDNA was quantified in biofilm su-
pernatants using QubitW 2.0 Fluorometer (Invitrogen;
Eugene, Oregon, USA), after ethanol precipitation. For
some experiments, biofilms were formed in the presence
of DNase I (28U/well or 56U/well Invitrogen; Carlsbad,
California, EUA).
Animal model
A pair of isolates showing differential agr expression
(08–008, agr-dysfunctional, obtained from BSI and 96/05,
agr-functional, from CT) was used. The mouse subcutane-
ous catheter implant model was described in detail by
Ferreira et al. [28]. Briefly, two intravenous polyurethane
catheter segments (C-UDLM-953J model; Cook Medical,
Bloominaton, USA) were implanted in the back of each
anesthetized young-adult BALB/c male mice. Infection was
induced 24 h after the implantation procedure by injecting
a mid-exponential growth phase culture (106 CFU/10 μL)
into the lumen of the implanted catheter segment. The
animal was euthanized after three days post-infection, and
the catheter segments were surgically removed to assess
the biofilm by counting catheter-adherent bacteria by
CFU determination. Three independent experiments were
performed. The animal study was approved (#IMPPG013)






rnaIII F: AATTTGTTCACTGTGTCGATAAT 135 This study
R:TGGAAAATAGTTGATGAGTTGTT
sarA F: TTCTTTCTCTTTGTTTTCGCTG 115 This study
R: GTTATCAATGGTCACTTATGCT
spa F: TGGTTTGCTGGTTGCTTCTTA 116 This study
R: GCAAAAGCAAACGGCACTAC
hla F: TTTGTCATTTCTTCTTTTTCCCA 169 This study
R: AAGCATCCAAACAACAAACAAAT
psmα F:TATCAAAAGCTTAATCGAACAATTC 176 53
R: CCCCTTCAAATAAGATGTTCATATC
sasG F:GGTTTTCAGGTCCTTTTGGAT 192 This study
R:CTGGTGAAGAGCGAGTGAAA
fnbpA F: ACTTGATTTTGTGTAGCCTTTTT 185 This study
R:GAAGAAGCACCAAAAGCAGTA
fnbpB F:CGTTATTTGTAGTTGTTTGTGTT 118 This study
R:TGGAATGGGACAAGAAAAAGAA
rrna 16S F: AGAGATAGAGCCTTCCCCTT 84 This study
R:TTAACCCAACATCTCACGACA
mecA F:TCCAGATTACAACTTCACCAGG 162 54
R:CCACTTCATATCTTGTAACG
aF and R: forward and reverse primers, respectively, in 5´→ 3´orientation. The
cycling conditions for all primers were as follows: One cycle of 48°C/30min
and 95°C/10 min, followed by 35 cycles of 95°C/30s, 55°C/45s and 72°C/45 s.
Each run included a nontemplate and a gene-negative RNA controls.
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DNase activity
Difco™ DNase Test Agar (BD; Becton, Dickinson and
Company, Sparks, USA) was used to screen 17 USA400-
related MRSA, as recommended by the manufacturer.
Autolysis assay
Autolysin activity was measured in 8 selected isolates as
previously described [51], except that cells were grown
in TSB 1% Glc.
Hemolytic activity
The δ-hemolysin (Hld), encoded by the hld gene, is codified
within the rnaIII region and, consequently, the detection
of δ-hemolysin is an indicative of agr expression. Sixty
USA400-related isolates were screened for hemolytic
activity on sheep red blood (5%) agar plates (Plast Labor,
RJ, Brazil) as previously described [52].
Gene expression
For RNA preparations, bacterial cells grown in TSB
(18h/37°C; 250 rpm) were obtained in the exponential
phase (OD600nm = 0.3) and in the stationary phase.
Total RNA was prepared using the RNeasy Mini kit
(Qiagen; Maryland, USA) and quantified by the Qubit
2.0 Fluorometer. The RNA quality was analyzed by running
RNA-gel electrophoresis. The real-time quantitative PCR
(RT-qPCR) was carried out using Power SYBRW Green
RNA-to-CT
™ 1-Step Kit (Applied Biosystems; Foster city,
CA, USA) as recommended, using ΔΔCt comparative
method. The primers and run conditions used for rnaIII,
hla, psmα [53], sarA, mecA[54], spa, sasG, fnbA and
fnbB genes and for the endogenous control rrna 16S are
listed in Table 1. All primers designed for this study were
validated as recommended (Guide to Performing Relative
Quantitation of Gene Expression Using Real-Time
Quantitative PCR; Applied Biosystems). The run was
performed in the Step One™ Real Time PCR System
(Applied Biosystems). Data were analyzed using the
Step One Software 2.2 (Applied Biosystems).
Adherence and invasion kinetics
Bacterial adherence and invasion were investigated using
human bronchial epithelial cells (16HBE14o- cell line) as
described [14], except that monolayers were prepared
using Dulbecco´s Modified Eagle Medium (DMEM,
Low Glucose 1X; Gibco, Invitrogen, Grand Island, USA)
and 10% Fetal Bovine Serum (Gibco, Invitrogen). For
determining the colony forming units (CFU) of the
total adhered and invasive bacteria (CFUAI), infected
monolayers were washed twice in DMEM (to remove
non-adherent bacteria), incubated (5 min/37°C) with0.25% (wt/vol) trypsin (11,000 U/mg; Sigma; St. Louis,
MO USA), lysed (5 min/37°C) with 0.025% (vol/vol)
Triton X-100 (Sigma) and plated in TSA. For determining
the CFU of invasive bacteria (CFUI), infected monolayers
were washed twice in DMEM and incubated (20 min/37°C)
with 100 μg/mL lysostaphin (500 U/mg; Sigma) to lyse
adherent bacteria. Monolayers were washed twice and
incubated (5 min/37°C) with 0.25% (wt/vol) trypsin. The
epithelial cells were lysed (5 min/37°C) with 0.025%
(vol/vol) triton X-100 and plated. For each aliquot, the
total CFU in the supernatant was also determined (CFUS).
The CFU of adherent bacteria (CFUA) was obtained by
the formula: CFUA = CFUAI - CFUI. The percentages of
invasive or adherent bacteria were calculated considering as
100% the total CFU obtained by the sum of CFUAI + CFUS
for each aliquot. In addition to the USA400-related isolates,
the wild-type HC474, and the isogenic Δagr::tetM and
rnaIII-trans-complemented constructions were also used
for investigating bacterial invasion.
Statistical calculations
Student’s t-test (unpaired data) was used to compare the
means of the biofilm values and of the data from gene
expression experiments. In addition, correlation coefficient
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and the ability of ST1 isolates to accumulate strong or
weaker biofilms. This last test was also used to determine
the occurrence of linear correlation between mecA and
agr expressions [55]. Data were expressed in terms of
mean values obtained from at least three independent
experiments and three repetitions of each set.
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